Clinical Trials Browser

Phase 1/2 × Cancer Pain × 1 year × Clear all

NCT02522611 2026-01-23

Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

Phase 1/2 Not yet recruiting

Cancer Pain, Pain, Intractable

NCT07008703 2025-06-06

Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain

Phase 1/2 Recruiting

Cancer Pain